Results 51 to 60 of about 86,774 (206)

Spatio-temporal clustering of respiratory syncytial virus in Sakon Nakhon Province, Thailand, across the COVID-19 pandemic: A retrospective space–time scan analysis, 2019–2024

Creative Science
Respiratory syncytial virus (RSV) is a leading cause of acute respiratory infections in young children and older adults. The COVID-19 pandemic and the implementation of non-pharmaceutical interventions (NPIs) profoundly altered the transmission dynamics ...
Kulwadee Suwannatrai, Kavin Thinkhamrop, Komsan Raksaseng, Apiporn Suwannatrai   +3 more
doaj   +1 more source

Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians

Pediatric Reports, 2023
Respiratory Syncytial Virus (RSV) is a leading cause of morbidity and hospitalization in all infants. Many RSV vaccines and monoclonal antibodies (mAb) are currently under development to protect all infants, but to date preventive options are available ...
Matteo Riccò, Silvia Corrado, Milena Pia Cerviere, Silvia Ranzieri, Federico Marchesi   +4 more
doaj   +1 more source

Genome structures of the rHPIV3-RSV-F vectors.

, 2020
The codon-optimized RSV F ORF containing the HEK and DS-Cav1 mutations (see Results) was engineered to contain an optimal translational start site (underlined and labeled “Kozak” [36]) and was flanked by HPIV3 gene-end (GE) and gene-start (GS ...
Sonja Surman (185609), Barney S. Graham (7400855), Xiang Liu (119470), Emerito Amaro-Carambot (185611), Xueqiao Liu (765408), Peter L. Collins (7252565), Peter D. Kwong (161423), Shirin Munir (223824), Bo Liang (450389)   +8 more
core   +1 more source

Impact of COVID-19 pandemic on the etiology and severity of respiratory viral infections in children

Вопросы вирусологии
Objective. To analyze the age-related characteristics of the contribution of influenza viruses, RSV, SARS-CoV-2, other pathogens to the development of severe acute respiratory infections (SARI) in children with an assessment of the disease severity ...
Anna А. Sominina, Darya M. Danilenko, Andrey B. Komissarov, Artem V. Fadeev, Ksenia S. Komissarova, Maria M. Pisareva, Tamila D. Musayeva, Veronika A. Eder, Tatiana P. Levanyuk, Kirill A. Stolyarov, Vera Z. Krivitskaya, Ekaterina R. Petrova, Olga I. Afanasyeva, Veronika S. Timonina, Elena V. Obraztsova, Ekaterina G. Golovacheva, Elena A. Dondurey, Evgenya V. Lelenkova, Olga G. Kurskaya, Alexander M. Shestopalov, Dmitry A. Lioznov   +20 more
doaj   +1 more source

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults

Human Vaccines & Immunotherapeutics, 2021
Respiratory Syncytial Virus (RSV) causes lower respiratory tract infections that can be severe and sometimes fatal. The risk for severe RSV infection is highest in infants and older adults.
Antonios O. Aliprantis, Christine A. Shaw, Paul Griffin, Nicholas Farinola, Radha A. Railkar, Xin Cao, Wen Liu, Jeffrey R. Sachs, Christine J. Swenson, Heather Lee, Kara S. Cox, Daniel S. Spellman, Colleen J. Winstead, Igor Smolenov, Eseng Lai, Tal Zaks, Amy S. Espeseth, Lori Panther   +17 more
doaj   +1 more source

Clinical severity of RSV bronchiolitis

Health Science Reports, 2022
AbstractBackgroundStudies comparing the severity of respiratory syncytial virus (RSV) bronchiolitis to other viruses are inconclusive. Our study aimed to compare the severity of bronchiolitis according to the virus.MethodsData were collected from 1152 infants under one year of age admitted to Children's hospital for Wales, over the winter months of ...
Faris Hussain, Margarita Delgado Thompson, David Vick, Jack West, Martin Edwards   +4 more
openaire   +3 more sources

Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance [PDF]

, 2009
Background.Although necessary for developing a rationale for vaccination, the burden of severe respiratory syncytial virus (RSV) disease in children in resource‐poor settings remains poorly defined.
Cane, Patricia A, Nokes, D. James, English, M. (Mike), Ngama, Mwanajuma, Scott, J Anthony G, Medley, Graham F, Medley, Graham, Cane, Patricia, English, Mike, Munywoki, Patrick, Bett, Anne, Scott, J. Anthony G., Nokes, D James, Abwao, John   +13 more
core   +1 more source

Stability of expression of RSV F protein by rHPIV3-RSV-F vectors evaluated by a double-staining immunofluorescence plaque assay.

, 2020
Vero cells were inoculated with 10-fold serial dilutions of the P4 stock of F-H3TMCT/N-P obtained from terminal dilution from transfection #1 and P2 stocks of F/preN, F-H3TMCT/preN, and F/N-P from transfection #2 (see Results).
Sonja Surman (185609), Barney S. Graham (7400855), Xiang Liu (119470), Emerito Amaro-Carambot (185611), Xueqiao Liu (765408), Peter L. Collins (7252565), Peter D. Kwong (161423), Shirin Munir (223824), Bo Liang (450389)   +8 more
core   +1 more source

Severe Rhabdomyolysis Associated With RSV [PDF]

Open Forum Infectious Diseases, 2017
AbstractSevere rhabdomyolysis is associated with morbidity and mortality. We report on a previously well male who developed severe rhabdomyolysis, sepsis, and multi-organ failure. The patient made a complete recovery. Extensive microbiological testing was only positive for RSV, making this the first reported case of adult RSV-related rhabdomyolysis in ...
Bender, J, Chew, R, Lin, BB, Athan, E
openaire   +5 more sources

Immunity to RSV in Early-Life [PDF]

Frontiers in Immunology, 2014
Respiratory Syncytial Virus (RSV) is the commonest cause of severe respiratory infection in infants, leading to over 3 million hospitalizations and around 66,000 deaths worldwide each year. RSV bronchiolitis predominantly strikes apparently healthy infants, with age as the principal risk factor for severe disease. The differences in the immune response
Lambert, L, Sagfors, AM, Openshaw, PJ, Culley, FJ   +3 more
openaire   +4 more sources